Biosimilars in Cancer is a comprehensive resource on the role of biosimilars in treating various cancer types. The book offers a succinct yet thorough overview of current trends in oncology, covering 21 different cancers from liver to breast cancer. Chapters provide detailed insights into trends, fundamental facts, and practical and clinical data, making it an invaluable tool for academics and practitioners. The book empowers researchers and clinicians to enhance understanding and improve patient outcomes through the effective use of biosimilars in oncology. Targeted primarily at pharmaceutical researchers, biomedical scientists, and clinicians, it supports the growing oncology biosimilars market.
In addition, the book provides critical insights for those involved in cancer diagnostics and clinical trials, helping them stay ahead in this rapidly progressing field.
- Offers detailed information on 21 different cancer types, ensuring a broad understanding of biosimilar applications in oncology
- Presents up-to-date insights into the rapidly evolving field of cancer treatment, helping researchers and clinicians stay ahead
- Integrates fundamental facts with practical and clinically relevant data, making it a valuable resource for academic and clinical purposes
